The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
What are the risks of COVID-19 infection in pregnant women?
Open accessAbstract
Since December, 2019, the outbreak of the 2019 novel coronavirus disease (COVID-19) infection has become a major epidemic threat in China. As of Feb 11, 2020, the cumulative number of confirmed cases in mainland China has reached 38 800, with 4740 (12·2%) cured cases and 1113 (2·9%) deaths; additionally, there have been 16 067 suspected cases so far. All 31 provinces in mainland China have now adopted the first-level response to major public health emergencies. The National Health Commission of China has published a series of guidelines on the prevention, diagnosis, and treatment of COVID-19 pneumonia, based on growing evidence of the pathogens responsible for COVID-19 infection, as well as the epidemiological characteristics, clinical features, and the most effective treatments. The central government and some provincial governments have provided food and medical supplies and dispatched expert groups and medical teams to manage and control the outbreak response in the hardest-hit areas (Wuhan and neighbouring cities in Hubei province). As the COVID-19 outbreak unfolds, prevention and control of COVID-19 infection among pregnant women and the potential risk of vertical transmission have become a major concern. More evidence is needed to develop effective preventive and clinical strategies. The latest research by Huijun Chen and colleagues reported in The Lancet provides some insight into the clinical characteristics, pregnancy outcomes, and vertical transmission potential of COVID-19 infection in pregnant women. Although the study analysed only a small number of cases (nine women with confirmed COVID-19 pneumonia), under such emergent circum stances these findings are valuable for preventive and clinical practice in China and elsewhere. Although neonatal nasopharyngeal swab samples have been collected in some hospitals across China, this study also collected and tested amniotic fluid, cord blood, and breastmilk samples for the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus allowing a more detailed assessment of the vertical transmission potential of COVID-19 infection. SARS-CoV-2 is a new strain of coronaviruses that are pathogenic to humans. Another two notable strains are SARS-CoV and the Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV). A study done by Roujian Lu and colleagues found that although SARS-CoV-2 is genetically closer to two bat-derived SARS-like coronaviruses, bat-SL-CoVZC45 and batSL-CoVZXC21 (with about 88% genome sequence identity), than to SARS-CoV-1 (about 79% identity) and MERS-CoV (about 50% identity), homology modelling has revealed that SARS-CoV-2 has a similar receptorbinding domain structure to that of SARS-CoV-1, which suggests that COVID-19 infection might have a similar pathogenesis to SARS-CoV-1 infection. Thus, the risk of vertical transmission of COVID-19 might be as low as that of SARS-CoV-1. The present study by Chen and colleagues did not find any evidence of the presence of SARS-CoV-2 viral particles in the products of conception or in neonates, in accordance with the findings of a previous study on SARS-CoV-1 done by Wong and colleagues. Two neonatal cases of COVID-19 infection have been confirmed so far, with one case confirmed at 17 days after birth and having a close contact history with two confirmed cases (the baby’s mother and maternity matron) and the other case confirmed at 36 h after birth and for whom the possibility of close contact history cannot be excluded. However, no reliable evidence is as yet available to support the possibility of vertical transmission of COVID-19 infection from the mother to the baby. Previous studies have shown that SARS during pregnancy is associated with a high incidence of adverse maternal and neonatal complications, such as spontaneous miscarriage, preterm delivery, intrauterine growth restriction, application of endotracheal intubation, admission to the intensive care unit, renal failure, and disseminated intravascular coagulopathy. However, pregnant women with COVID-19 infection in the present study had fewer adverse maternal and neonatal complications and outcomes than would be anticipated for those with SARS-CoV-1 infection. Although a small number of cases was analysed and the findings should be interpreted with caution, the findings are mostly consistent with the clinical analysis done by Zhu and colleagues of ten neonates born to mothers with COVID-19 pneumonia. The clinical characteristics reported in pregnant women with confirmed COVID-19 infection are similar to those reported for non-pregnant adults with confirmed COVID-19 infection in the general Published Online February 12, 2020 https://doi.org/10.1016/ S0140-6736(20)30365-2
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Chen, H., Guo, J., Wang, C., Luo, F., Yu, X., Zhang, W., Li, J., Zhao, D., Xu, D., Gong, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30360-3 · Cited by 3,919
Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia
Zhu, H., Wang, L., Fang, C., Peng, S., Zhang, L., Chang, G., Xia, S., & Zhou, W. (2020) · Translational Pediatrics · doi:10.21037/tp.2020.02.06 · Cited by 1,426
Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome
Wong, S. F., Chow, K. M., Leung, T. N., Ng, W. F., Ng, T. K., Shek, C. C., Ng, P. C., Lam, P. W. Y., Ho, L. C., To, W. W. K., et al. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.11.019 · Cited by 1,049
Lam, C. M., Wong, S. F., Leung, T. N., Chow, K. M., Yu, W. C., Wong, T. Y., Lai, S. T., & Ho, L. C. (2004) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2004.00199.x · Cited by 303
To, K., & Lo, A. W. (2004) · The Journal of Pathology · doi:10.1002/path.1597 · Cited by 226
Cited by
Schwartz, D. A. (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0901-sa · Cited by 976
Qiao, J., Wang, Y., Li, X., Jiang, F., Zhang, Y., Ma, J., Song, Y., Ma, J., Fu, W., Pang, R., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32708-2 · Cited by 569
Self-citationWhy are pregnant women susceptible to COVID-19? An immunological viewpoint
Liu, H., Wang, L.-L., Zhao, S.-J., Kwak-Kim, J., Mor, G., & Liao, A.-H. (2020) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2020.103122 · Cited by 518
Li, N., Han, L., Peng, M., Lv, Y., Ouyang, Y., Liu, K., Yue, L., Li, Q., Sun, G., Chen, L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa352 · Cited by 486
Coronavirus (COVID 19) Infection in Pregnancy
Ortiz, E. I., Castañeda, E. H., & De La Torre, A. (2020) · Colombia Medica · doi:10.25100/cm.v51i2.4271 · Cited by 391
Metadata
- Authors
- Qiao, J.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 395
- Issue
- 10226
- Pages
- 760-762
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W3006304225
- Cited by
- 469
- References
- 9
- FWCI
- 57.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: What are the risks of COVID-19 infection in pregnant women? https://app.cochat.ai/papers/10.1016/s0140-6736(20)30365-2
- The paper
- Qiao, J. (2020). What are the risks of COVID-19 infection in pregnant women? The Lancet. https://doi.org/10.1016/s0140-6736(20)30365-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.